Cognitive-Motor Training With the DextEgg in Children With ADHD (ADHD DextEgg)

November 3, 2026 updated by: Manuela Pastore-Wapp

Investigating the Relationship Between Fine Motor Skills and Cognitive-Motor Training in Children With ADHD: a Randomized Controlled Trial

Attention Deficit Hyperactivity Disorder (ADHD) is frequently accompanied by deficits in executive functions and fine motor skills, which affect daily activities, academic performance, and health-related quality of life. The DextEgg is a gamified hand-training device with motion and pressure sensors that connects to a tablet app and allows fine motor exercises to be combined with cognitive demands (inhibition, working memory, cognitive flexibility). This single-center randomized controlled trial evaluates whether a 4-week home-based cognitive-motor training with the DextEgg improves fine motor skills and executive functions in children aged 8 to 12 years with ADHD, compared with a motor-only DextEgg training of identical dose. Fifty children will be randomized 1:1 and complete 20 home-based sessions (5 per week, 35 minutes each). Assessments take place at baseline, after the intervention, and at 3-month follow-up.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

8 years to 13 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age 8 years 0 months to 12 years 11 months
  • Clinical ADHD diagnosis according to DSM-5, confirmed by a physician or psychologist
  • Written informed consent by legal guardian and assent by the child
  • Caregiver-reported difficulties in fine motor tasks (e.g., handwriting, tying shoes)
  • Caregiver-reported executive functioning difficulties in daily life

Exclusion Criteria:

  • Any other significant neurological, developmental, or psychiatric condition that could affect fine motor or cognitive functioning
  • Participation in another intervention study during the study period
  • Inability to follow study procedures due to language difficulties or other barriers

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Cognitive-Motor DextEgg Training

20 home-based sessions over 4 weeks (5x/week, 35 min): finger-specific dexterity exercises with embedded cognitive challenges (inhibition, working memory, cognitive flexibility), adaptive difficulty

Gamified, app-guided home training with the DextEgg (sensor-equipped hand trainer connected via Bluetooth to a tablet) combining fine motor tasks (tapping, squeezing, rolling) with inhibition, working memory and cognitive-flexibility demands. Other names: Smart Sensor Egg (SSE).

Active Comparator: Motor-Only DextEgg Training

Same schedule, device and fine motor tasks, but without embedded cognitive challenge

Identical fine motor sequences with the DextEgg without dual-task or rule-switching elements; controls for device use, motor activity and training time.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fine motor skills (M-ABC-3 fine motor coordination)
Time Frame: Baseline, post-intervention (week 5), 3-month follow-up

Movement Assessment Battery for Children, 3rd edition, fine motor coordination subscale (placing pegs, threading lace, drawing trail)

Baseline, post-intervention (week 5), 3-month follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional dexterity
Time Frame: Baseline, post-intervention (week 5), 3-month follow-up

Functional Dexterity Test (FDT)

Baseline, post-intervention (week 5), 3-month follow-up
Inhibitory control
Time Frame: Baseline, post-intervention (week 5), 3-month follow-up

D-KEFS Color Word Interference Test, Part III

Baseline, post-intervention (week 5), 3-month follow-up
Cognitive flexibility
Time Frame: Baseline, post-intervention (week 5), 3-month follow-up

D-KEFS Color Word Interference Test, Part IV

Baseline, post-intervention (week 5), 3-month follow-up
Verbal working memory
Time Frame: Baseline, post-intervention (week 5), 3-month follow-up

WISC-V Digit Span (forward and backward)

Baseline, post-intervention (week 5), 3-month follow-up
Visual working memory
Time Frame: Baseline, post-intervention (week 5), 3-month follow-up

WISC-V Picture Span

Baseline, post-intervention (week 5), 3-month follow-up
Attention
Time Frame: Baseline, post-intervention (week 5), 3-month follow-up

TAP subtests Go/No-Go and Divided Attention

Baseline, post-intervention (week 5), 3-month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 1, 2026

Primary Completion (Estimated)

July 31, 2028

Study Completion (Estimated)

October 31, 2028

Study Registration Dates

First Submitted

October 28, 2026

First Submitted That Met QC Criteria

October 28, 2026

First Posted (Actual)

November 3, 2026

Study Record Updates

Last Update Posted (Actual)

November 5, 2026

Last Update Submitted That Met QC Criteria

November 3, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • ADHD DextEgg
  • BASEC (Other Identifier: 2026-00938)
  • SNCTP (Other Identifier: SNCTP000006929)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.